insights_auto
Why is DC4 up 3.00%?
Dive Deeperchevron_right
DC4:FRA
DexCom Inc
€75.60
arrow_upward
+3.00%(+2.20) 1D
Nov 13, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DC4...
Open
€73.20
High
€75.60
Low
€73.20
Mkt. cap
31.08B
Avg. vol.
66.00
Volume
0.00
52-wk high
€79.60
52-wk low
€48.50
No. of employees
11K
Open
€73.20
High
€75.60
Low
€73.20
Mkt. cap
31.08B
Avg. vol.
66.00
Volume
0.00
52-wk high
€79.60
52-wk low
€48.50
No. of employees
11K
News stories
From web sources and news partners
Investing.com
·
19 minutes ago
DexCom director Nicholas Augustinos sells $679,768 in stock
Investing.com Nigeria
·
34 minutes ago
Form 4 DexCom Inc: Nicholas Augustinos (Director) For: 14 September By Investing.com
Zacks Investment Research
·
2 days ago
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
Profile
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
About DexCom Inc
CEO-
Employees11K
Founded1999
HeadquartersSan Diego, California, United States
SectorHealth Care
IndustryMedical device
Websitedexcom.com